By Simply Wall St
Publication Date: 2026-05-13 13:20:00
Get insights on thousands of stocks from the global community of over 7 million retail investors at Simply Wall St.
-
Oracle (NYSE:ORCL) has Dr. Tomislav Mihaljevic, CEO and President of the Cleveland Clinic, has been appointed to its Board of Directors.
-
The company has also expanded its partnership with Samsung Electronics, with Samsung looking to standardize global semiconductor software development on Oracle Java.
Oracle comes into these announcements with a stock price of $186.83 and a Value Score of 4, along with a return of 16.3% over the past year and a return of 154.0% over the past 5 years. For investors, the combination of a healthcare leader on the board and a deeper role in semiconductor software development helps clarify where Oracle is focusing its efforts across sectors.
The board’s appointment and partnership with Samsung could impact how Oracle positions its software and cloud offerings with healthcare and semiconductor customers. Readers may want to observe how these steps play out…